siENDOD1-induced pRPA32 foci were increased in serum-starved (G1 phase) cancer lines harbouring a TP53 null allele (SKOV-3 and NCI-H1299) in addition to cancer cells harbouring gain-of-function (GOF) mutants R273C (C33A) and R273H (MBA-MD-468). Here, TP53 is linked to cancer.